Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Xingnaojing in acute ischemic stroke
NCT04150835Phase 4Unknown
- Sponsor
- Dongzhimen Hospital of Beijing University of Traditional Chinese Medicine
- Start
- Mar 2020
- Primary completion
- Dec 2021
- Modality
- HM (Herbal Medicine), Combination Drug
- Countries
- 1
01
Overview
A Phase 4 trial of Xingnaojing injection in ischemic stroke, sponsored by Dongzhimen Hospital of Beijing University of Traditional Chinese Medicine. Status: unknown.
02
Drugs
Xingnaojing injection
03
Conditions
ischemic stroke
Beyond the preview
Go deeper on NCT04150835.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04150835.